United Kingdom · Report · Written statement
UIN HCWS545
Covid-19 Update
Introduced
19 January 2022
Last action
19 January 2022 · Written statement
Status
Commons
Sponsors
—
Subjects
Discovery layer
Source updated
19 January 2022
Summary
Departmental Contingent Liability Notification (deployment of the novel oral antiviral drug PF-07321332+ritonavir)I am making this statement for the benefit of Honourable and Right Honourable members to bring to their attention a contingent liability the ...
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
19 January 2022
Written statement
Departmental Contingent Liability Notification (deployment of the novel oral antiviral drug PF-07321332+ritonavir)I am making this statement for the benefit of Honourable and Right Honourable members to bring to their attention a contingent liability the ...
Source: Commons
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-statements/detail/2022-01-19/HCWS545
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenstatements/statements/1404234
- uk · ws-1404234 · source updated 19 January 2022